Ophthalmology Device Articles & Analysis
8 news found
MINIject is a potentially best-in-class minimally-invasive glaucoma surgery (MIGS) implant and the only commercially available supraciliary MIGS device. The trial is now initiated in 13 sites across the US with positive feedback on initial implantations from world-leading glaucoma surgeons. ...
Unlike other proposed sensors, the Injectsense device minimizes patient intervention through its autonomous data collection. “The ophthalmology community needs a device that can be placed in the eye to monitor IOP, day and night, continuously for the lifetime of a patient. ...
He also previously served as Director, Clinical Development at Allergan in the Ophthalmology Therapeutic Area, as Clinical Scientist on several Phase 1, 2, and 3 studies. ...
I have now used the Hydrus for over 5 years, and a few things about this data set stand out. First, the device effect is remarkably consistent over time, which is critical when remembering that glaucoma is a long-term disease. ...
SPECTRUM, the world’s largest single-device registry in ophthalmology, has completed enrollment. The announcement was made today by Ivantis Inc., a company dedicated to developing new and innovative solutions for glaucoma. ...
CAMPBELL, CA – September 11, 2019 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a novel modular presbyopia- correcting intraocular lens (IOL), today announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris, France. The first presentation will ...
Injectsense, Inc. an innovative medical device firm that develops sensor-enabled digital health systems to measure therapy effectiveness, announced today additional members of its medical advisory board. ...
The award will enable Dr Yogesan Kanagasingam, Research Director for the Australian e-Health Research Centre (AEHRC), to spend four months at Stanford University School of Medicine developing and validating a new ‘non-invasive’ system to screen newborn babies. CSIRO Chief Executive, Dr Megan Clark, said Dr Kanagasingam’s work has application across a wide range of areas, ranging from remote, ...